A Randomized, Single-blind Study With a Parallel Control Group on the Efficacy and Safety of Bemiparin at Therapeutic Dose vs. Prophylactic Dose in Patients Hospitalized for COVID-19
Latest Information Update: 20 Sep 2023
At a glance
- Drugs Bemiparin sodium (Primary)
- Indications Blood coagulation disorders; COVID 2019 infections; Pneumonia
- Focus Therapeutic Use
Most Recent Events
- 03 Jun 2022 Status changed from recruiting to discontinued.
- 05 Jun 2020 Status changed from planning to recruiting.
- 22 Apr 2020 New trial record